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1078-l 78 Application of Synthetic CDK lnhibitlon (Flavopiridol) as 
a Novel Therapeutic Strategy to Effectively Limit 
Common Pathways of In-Stent Restenosis: 
Characterization of Molecular Effects and Applicability 
on Drug Coated Stents 
Birgit Jaschke, Franziska Wegener, Sr., Rainer Wessely, Deutsches Herzzentrum. 
Muenchen. Germany 
The cellular component of in-stem restenotic lesions is mainly comprised of proliferated 
and migrated coronary artery smooth muscle cells (CASMC). Early ceil cycle inhibition 
represents an attractive therapeutic strategy. Cyclin-dependent kinases (CDK) trigger 
and coordinate transitions between different phases of the cell cycle. Flavopiridol (FLA) 
is a highly effective synthetic CDK inhibitor. The main purpose of the study was to deter- 
mine the efficacy and molecular effects of FLA in limiting mitogen induced CASMC prolif- 
eration and migration as well as to examine the effects of FLA coated stems on the 
prevention of in-stem restenosis. Results: FLA displayed potent anti-proliferative effects 
in CASMC, the IC50 was determined at 75 nM (BrdU ELISA. cell counting). Accordingly, 
CASMC CDW, 4 and PCNA protein levels were dose dependently downregulated. Cell 
cycle analysis by propidium iodine flow cytometry revealed a Gt arrest in Flavopirldol 
treated CASMC. Given the potent anti-restenotic effects of Sirolimus coated stems, 
upregulated levels of endogenous CDK inhibitors such as p21 and particularly p27 may 
be critical for effective anti-restenotic therapy. FLA lead to a dose dependent increase of 
p21 and p27 protein levels in CASMC. FLA prevented p27 degradation. At concentra- 
tions of lOOnM, there was neither evidence of FLA induced cytotoxicity (LDH release 
ELISA) nor apoptosis (ssDNA ELISA). A Boyden chamber assay revealed significant 
reduction of CASMC migration towards a fibronectin gradient by more than 50% at 100 
nM. FLA coated stents lead to significant inhibition of CASMC proliferation in an in vitro 
model (FLA 137+/-12 cells, control 454~1-46, p<O.Ol). Initial results in an ongoing study 
using a rat carotid stenting model indicate reduced neointima formation in animals 
treated with FLA coated stents. Conclusions: Flavopiridol displays potent anti-restsnotic 
effects. CDK inhibition by novel synthetic compounds such as Flavopiridol via drug 
coated stems may be an effective approach to limit neointima formation following stem 
placement and highlights the importance of early cell cycle inhibition as an effective tool 
to limit restenotic processes. 
1078-l 79 Interferon Gamma Receptor 1 88 G/A Polymorphism 
and Restenosie Following Coronary Artery Stenting 
Klaus A. Tiroch, Olga Gorchakova, Werner Koch, Petra Hoppmann. Angela Ehrenhaft, 
Wolfoano L&z. Nicolas van Beckerath. Albert Schomia. Adnan Kastrati. Deutsches 
He&en&urn MOnchen, Munich, Germany, 1. Medizinische Klinik der Technischen 
Universitat Munchen. Munich, Germany 
Background: Recently, upregulation of interferon gamma related genes has been found 
in human neointima of restenotic lesions following coronary artery stenting. The func- 
tional single nucleotide polymorphism 66GlA is located inside the signal peptide of the 
interferon gamma receptor 1 and results in an amino acid substitution (ValldMet). The 
objective of this study was to assess the influence of this polymorphism on restenosis. 
Methods: This is a case control study. Subjects of both groups were nondiabetics with 
stenting in 2 or more vessels and follow-up angiography at 6 months. Cases were 
selected to have restenosis in at least 2 stented lesions and controls no restenosis at all. 
Each group consisted of 41 consecutive patients fulfilling these criteria. Genotyping was 
performed with nested PCR and restriction enzyme analysis. 
Results: Cases were 67.6+12.9 years old, controls 67.5+12.0 years. None of the cases 
or controls were homozygous for the rarer A allele. An excess of A allele carriers was 
observed among cases with restenosis as compared to controls (Figure). 
Conclusions: Interferon gamma receptor 1 66GlA polymorphism may have an influence 
on the development of restenosis following coronary artery stenting. This may be related 
to a shift of ThlKhP balance described for A allele carriage. 
1078-l 80 Circulatory Endothelial Precursor Cells and Neural- 
Crest Derived Cells in Human In-Stent Restenosis 
Dirk Skowasch. Kristina Yeahiazawan Sabine Dinkelbach, Alexander Jabs, Bemdt 
LOderitz, Gerhard Bauriedel, University of Bonn, Bonn, Germany 
Background: In-stem restenosis (ISR) is a major limitation of interventional cardiology. 
Circulatory endothelial precursor cells and neural crest derived cells might contribute to 
neointimal formation as reparation cells. Therefore, the objective of the present study 
was to evaluate CD34 and CD133 as markers of bone-marrow derived cells, and cal- 
cium-binding protein SIOO, glial fibrillary acidic protein (GFAP), neuron-specific enolase 
(NSE) and nerve growth factor receptor (NGFR) as markers for neural crest derived cells 
in ISR Methods: Atherectomy specimens from 10 patients with coronary (post-stem 
implantation 6$3) months), 7 patients with peripheral ISR (723) and 10 with primary 
lesions were studied by immunohistochemistry for the presence of each determinant. 
Results: Samples from ISR consrstently demonstrated a homogeneous hypercellularity 
(12122546 celUmm2 III coronary, 10612257 in peripheral ISR, 665+96 in primary 
lesions). As a key finding, expression of each marker was significantly increased in ISR 
compared to primary lesions (each P.zO.05; Table). In addition, we found positive correla- 
tions for cells of bone-marrow and neural-crest origin. Conclusion: The present study 
demonstrates the presence of intimal cells of bone marrow and neural crest origin in dif- 
ferent types of coronary and peripheral atherosclerosis. Their significant expression in 
human ISR suggests an important role of these cells in this form of accelerated athero- 
sclerosis. 
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1078-181 The Effect of Carvedilol-Loaded SiodyvYsio Stent on 
Neointimal Hyperplasia in a Porcine Coronary Stent 
Restenosis Model 
Weon Kim,Mvuna Ho Jeonq Gwang Soo Cha. Young Joon Hong, Jeong Gwan Cho. 
Jong Chun Park, Jung Chaee Kang, Chonnam National University Hospital, Gwang Ju, 
South Korea, Dong A University Hospital, Busan, South Korea 
Background and Purpose: Catvedilol is a direct inhibitor of myofibroblast migration in 
the vascular media and adventitia and exhibits antioxidant properties. We assessed the 
efficacy of high concentration of carvedilol, loaded with BicdivYsioTM DD stent and deliv- 
ered directly into the vessel wall on the inhibition of neointimal proliferation after stenting 
in porcine coronary arteries. Methods: Total loading amount of carvedilol was deter- 
mined using 11 mm BiafivYsioTM Matrix LO stents in different concentration (5mglmL. 
25mg/mL, and 40mglmL) of carvedilol solution. Twenty-two BiodivYsi@ DD stems were 
implanted at 12 pigs, immediately after being immersed and dried in the different 
carvedilol or control solution. Quantitative angiographic analysis and histopathologic 
analysis was done 4 weeks later. Results: Total loading amounts of carvedilol on the 
BicdivYsioTM Matrix LO stents were 7il pg, 96t18 pg. and 217+34 pg from 5 mgiml, 25 
mglml, and 50 mglml carvedilol solution, respectively. Twenty-two stems were implanted 
and overexpanded successfully. No pig was dead during the 4-week observation. On 
quantitative coronary angiogram, the coronary artery diameters were not significantly dif- 
ferent between two groups before stenting or at 4 weeks after stenting. 
Table. Histopathologic analysis 
Control 5mglmL 25mgimL 4OmglmL P value 
Injury score 1.60*0.63 1.92*0.64 1.92iO.64 1.76~0.59 0.69 
EIL area (mm*) 7.17+0.97 7.15t0.60 6.36iO.43 6.76tl.16 0.067 
IIL area (mm? 5.35*0.75 6.06*0.56 5.23*0.61 5.57*1.12 0.084 
Lumen area (mms) 3.7220.78 5.16*0.66 3.92iO.66 4.44tl.40 0.004’ 
Neointima (mm? 1.63i0.56 0.8&0.30 1.3liO.73 1.13+0.57 0.022’ 
Diameter stenosis (%) 30.5*10.5 14.625.2 25.2~13.4 21.7kl4.5 0.016’ 
’ P.zO.05 between 5 mg/ml and control solution. 
Conclusions: Low dose carvedilol-loaded BiodivYsidM Matrix LO stems inhibit stem 
restenosis in porcine coronary stem restenosis model. 
1078-l 82 Innate lmmunomodulation via Transient Depletion of 
Monocytes by Liposomal-Alendronate Suppresses 
Neointimal Formation Following Balloon and Stent 
Injury in Rabbits 
Haim D. Danenberq Gershon Golomb, Adam R. Groothuis, Philip Seifert. Elazer R. 
Edelman, Massachusetts Institute of Technology, Cambridge, MA, Hebrew University of 
Jerusalem, Jerusalem, Israel 
Background: Inflammation is a major trigger for the reparative events that follow vascular 
injury. Excessive innate immune response correlates with neointimal hyperplasia and 
restenosis. We studied the impact of transient systemic inactivation of monocytes and 
macrophages on intimal hyperplasia following balloon injury and stem deployment. 
Methods and Results: Bisphosphonates encapsulated in liposomes are phagocytosed by 
and specifically inactivate macrophages. Endothelial or smooth muscle cells that do not 
imbibe these formulations are left intact. Rabbits fed a hypercholesterolemic diet under- 
went bilateral iliac balloon denudation and stent deployment. Suppression of blood 
monocytes from 94tlt3 to l&15 I ml (p<O.Ol) was observed 46 hours after injury and 
intraarterial inJection of liposomal alendronate (3 mg/kg). Suppression was transient with 
return to normal levels a week after iniuw (flow cvtometrv for CDl4+ cells). The reduction 
in blood monocytes was associated with reduced infiltration by tissue macrophages (at 6 
davs. RAM-1 1 rmmunostainino). suooressed arterial cellular oroliferation (KI-67 immun- 
ostarning) and neointimal formation at 28 days. lntimal area was reduced by 47% 
(3.68*0.93 to 2.08t0.56 mm2), lumen area was increased by 24% (2.87eO.44 to 
3.57*0.65 mm2) and stenosis (%) was reduced by 25% (342 4 to 25* 4%) (mean&D, 
n=l6, peO.01 for all 3 parameters). 
Conclusions: Innate immunity triggers vascular repair; and when extreme, as in stented 
